Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Eastman Chemical (EMN) Research & Development (2016 - 2026)

Eastman Chemical (EMN) has disclosed Research & Development for 18 consecutive years, with $60.0 million as the latest value for Q1 2026.

  • For Q1 2026, Research & Development fell 10.45% year-over-year to $60.0 million; the TTM value through Mar 2026 reached $248.0 million, down 3.88%, while the annual FY2025 figure was $255.0 million, 2.0% up from the prior year.
  • Research & Development hit $60.0 million in Q1 2026 for Eastman Chemical, up from $58.0 million in the prior quarter.
  • Across five years, Research & Development topped out at $68.0 million in Q3 2022 and bottomed at $57.0 million in Q4 2023.
  • Average Research & Development over 5 years is $62.8 million, with a median of $63.0 million recorded in 2025.
  • Year-over-year, Research & Development increased 15.79% in 2024 and then decreased 12.12% in 2025.
  • Eastman Chemical's Research & Development stood at $64.0 million in 2022, then fell by 10.94% to $57.0 million in 2023, then rose by 15.79% to $66.0 million in 2024, then fell by 12.12% to $58.0 million in 2025, then rose by 3.45% to $60.0 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods came in at $60.0 million, $58.0 million, and $63.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.